Please assess the completion status of the following clinical trial:

Trial Title: Fenoldopam in Pediatric Cardiac Surgery

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Children with congenital heart disease, less than one year old, undergoing surgery with the use of cardiopulmonary bypass~Exclusion Criteria:~* Children over one year old, correction for ventricular or atrial septal defect, need for deep hypothermic circulatory arrest, preoperative renal dysfunction.

- Gender: ALL
- Minimum Age: 1 Day
- Maximum Age: 365 Days
- Healthy Volunteers: f

Study Arms:
- Placebo (Type: PLACEBO_COMPARATOR): Saline blinded infusion
- Fenoldopam (Type: ACTIVE_COMPARATOR): Drug infusion

Based on this trial design, predict the completion outcome and termination type (if applicable).